Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,331 | -278,482 | -212,659 | -143,003 | -75,971 |
| Depreciation Amortization | 6,620 | 21,641 | 14,730 | 16,095 | 7,092 |
| Accounts receivable | -4,658 | -1,060 | 4,944 | -777 | 1,241 |
| Accounts payable and accrued liabilities | -351 | 2,055 | -198 | -2,917 | -4,606 |
| Other Working Capital | -21,079 | 875 | 5,159 | -5,212 | -11,322 |
| Other Operating Activity | 24,682 | 68,680 | 56,373 | 43,688 | 28,246 |
| Operating Cash Flow | $-81,117 | $-186,291 | $-131,651 | $-92,126 | $-55,320 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,072 | -3,396 | 28,508 | 10,796 | 38,432 |
| PPE Investments | -630 | N/A | -161 | N/A | -131 |
| Purchase Sale Intangibles | -27,337 | -28,366 | -24,199 | -16,579 | -5,136 |
| Other Investing Activity | -27,337 | -29,157 | -24,199 | -16,727 | -5,136 |
| Investing Cash Flow | $-37,039 | $-32,553 | $4,148 | $-5,931 | $33,165 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 104,926 | 104,926 | 104,926 | 104,926 |
| Common Stock Issued | 218,125 | 24,130 | 23,899 | 20,492 | 19,667 |
| Other Financing Activity | -1,129 | -11,483 | -11,803 | -10,674 | -10,680 |
| Financing Cash Flow | $216,996 | $117,573 | $117,022 | $114,744 | $113,913 |
| Exchange Rate Effect | 848 | -2,794 | -3,935 | -2,681 | -939 |
| Beginning Cash Position | 61,688 | 165,753 | 165,753 | 165,753 | 165,753 |
| End Cash Position | 161,376 | 61,688 | 151,337 | 179,759 | 256,572 |
| Net Cash Flow | $99,688 | $-104,065 | $-14,416 | $14,006 | $90,819 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,117 | -186,291 | -131,651 | -92,126 | -55,320 |
| Capital Expenditure | -630 | N/A | -161 | N/A | -131 |
| Free Cash Flow | -81,747 | -186,291 | -131,812 | -92,126 | -55,451 |